298 related articles for article (PubMed ID: 26210200)
41. Challenges in the Treatment of Sarcomas of Adolescents and Young Adults.
Rotz SJ; Nagarajan R; Sorger JI; Pressey JG
J Adolesc Young Adult Oncol; 2017 Sep; 6(3):406-413. PubMed ID: 28665754
[TBL] [Abstract][Full Text] [Related]
42. [Acute lymphoblastic leukemia in adolescents and young adults].
Hayakawa F
Rinsho Ketsueki; 2015 Oct; 56(10):2032-8. PubMed ID: 26458442
[TBL] [Abstract][Full Text] [Related]
43. The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patients.
Ra HS; Shin SJ; Kim JH; Lim H; Cho BC; Roh MR
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e53-9. PubMed ID: 22329482
[TBL] [Abstract][Full Text] [Related]
44. Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions.
Shaw PH; Boyiadzis M; Tawbi H; Welsh A; Kemerer A; Davidson NE; Ritchey AK
Cancer; 2012 Jul; 118(14):3614-7. PubMed ID: 22213134
[TBL] [Abstract][Full Text] [Related]
45. Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults.
Mohan SR; Advani AS
J Adolesc Young Adult Oncol; 2011 Mar; 1(1):19-24. PubMed ID: 26812565
[TBL] [Abstract][Full Text] [Related]
46. Acute and late toxicity following adjuvant high-dose chemotherapy for high-risk primary operable breast cancer--a quality assessment study.
Svane IM; Homburg KM; Kamby C; Nielsen DL; Roer O; Sliffsgaard D; Johnsen HE; Hansen SW
Acta Oncol; 2002; 41(7-8):675-83. PubMed ID: 14651213
[TBL] [Abstract][Full Text] [Related]
47. Adolescent and Young Adult (AYA) Oncology in the United States: A Specialty in Its Late Adolescence.
Shaw PH; Reed DR; Yeager N; Zebrack B; Castellino SM; Bleyer A
J Pediatr Hematol Oncol; 2015 Apr; 37(3):161-9. PubMed ID: 25757020
[TBL] [Abstract][Full Text] [Related]
48. Understanding Causes of Inferior Outcomes in Adolescents and Young Adults With Cancer.
Wolfson JA; Kenzik KM; Foxworthy B; Salsman JM; Donahue K; Nelson M; Littrell MB; Williams GR; Levine JM
J Natl Compr Canc Netw; 2023 Aug; 21(8):881-888. PubMed ID: 37549915
[TBL] [Abstract][Full Text] [Related]
49. Sleep in Adolescents and Young Adults in the Year After Cancer Treatment.
Daniel LC; Aggarwal R; Schwartz LA
J Adolesc Young Adult Oncol; 2017 Dec; 6(4):560-567. PubMed ID: 28628351
[TBL] [Abstract][Full Text] [Related]
50. Disparities in Adolescents and Young Adults With Cancer.
Isenalumhe LL; Fridgen O; Beaupin LK; Quinn GP; Reed DR
Cancer Control; 2016 Oct; 23(4):424-433. PubMed ID: 27842332
[TBL] [Abstract][Full Text] [Related]
51. Association of Patient-Reported Health-Related Quality of Life With Physician-Reported Toxicities in Adolescents and Young Adults Receiving Radiation Therapy for Cancer.
Corrigan KL; Reeve BB; Salsman JM; Siembida EJ; Smith GL; Swartz MC; Lee KL; Afridi F; Andring LM; Bishop AJ; Gunther JR; Livingston JA; Peterson SK; Parsons SK; Roth M
JCO Oncol Pract; 2023 Aug; 19(8):610-619. PubMed ID: 37311165
[TBL] [Abstract][Full Text] [Related]
52. Risk assessment of drug interaction potential and concomitant dosing pattern on targeted toxicities in pediatric cancer patients.
Barrett JS; Patel D; Dombrowsky E; Bajaj G; Skolnik JM
AAPS J; 2013 Jul; 15(3):775-86. PubMed ID: 23595361
[TBL] [Abstract][Full Text] [Related]
53. Rhabdomyosarcoma of the Breast in Adolescent and Young Adult (AYA) Women.
Audino AN; Setty BA; Yeager ND
J Pediatr Hematol Oncol; 2017 Jan; 39(1):62-66. PubMed ID: 27879537
[TBL] [Abstract][Full Text] [Related]
54. Adolescent and young adult (AYA) lymphoma survivors report lower health-related quality of life compared to a normative population: results from the PROFILES registry.
Husson O; Prins JB; Kaal SE; Oerlemans S; Stevens WB; Zebrack B; van der Graaf WT; van de Poll-Franse LV
Acta Oncol; 2017 Feb; 56(2):288-294. PubMed ID: 28077017
[TBL] [Abstract][Full Text] [Related]
55. Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults.
Keegan TH; Ries LA; Barr RD; Geiger AM; Dahlke DV; Pollock BH; Bleyer WA;
Cancer; 2016 Apr; 122(7):1009-16. PubMed ID: 26848927
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003.
Hough R; Rowntree C; Goulden N; Mitchell C; Moorman A; Wade R; Vora A
Br J Haematol; 2016 Feb; 172(3):439-51. PubMed ID: 26683485
[TBL] [Abstract][Full Text] [Related]
57. Acute lymphoblastic leukemia in adolescents and young adults.
Burke PW; Douer D
Acta Haematol; 2014; 132(3-4):264-73. PubMed ID: 25228551
[TBL] [Abstract][Full Text] [Related]
58. Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.
Tomizawa D; Watanabe T; Hanada R; Horibe K; Horikoshi Y; Iwamoto S; Kinoshita A; Moritake H; Nakayama H; Shimada A; Taga T; Takahashi H; Tawa A; Terui K; Hori H; Kawano Y; Kikuta A; Manabe A; Adachi S
Int J Hematol; 2015 Sep; 102(3):318-26. PubMed ID: 26126642
[TBL] [Abstract][Full Text] [Related]
59. Toxicities and Associated Factors in Patients Receiving Temozolomide-Containing Regimens: A 12-Year Analysis of Hospital Data.
Shi C; Wang X; Diao C; Zhu H; Yuan Q; Liu J; Li S; Gu M; Zhang Y
Drug Des Devel Ther; 2021; 15():2151-2159. PubMed ID: 34045849
[TBL] [Abstract][Full Text] [Related]
60. An exploratory study of oncology specialists' understanding of the preferences of young people living with cancer.
Thompson K; Dyson G; Holland L; Joubert L
Soc Work Health Care; 2013; 52(2-3):166-90. PubMed ID: 23521383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
